- 11 hrs ago Amazon Great Indian Festival: Up To 50% Off On Protein Powders
- 12 hrs ago Remedial Measures In Astrology To Counter Different Problems In Life
- 15 hrs ago Weekly Horoscope, 02 October To 08 October 2022, Check This Week Horoscope Prediction For All Zodiac Signs
- 17 hrs ago Daily Horoscope, 02 October 2022: Today's Horoscope Predictions For All Zodiac Signs
- Movies Bigg Boss 16 Day 1 Live Updates: And So, On The Very First Day, #KhelGayeBiggBoss
- Sports Legends League Cricket: Taylor, Nurse’s blazing knocks power India Capitals to final
- News Intelligence dept gets input about threat to Maha CM Shinde's life; security beefed up
- Finance Post Office Saving Schemes Interest Rates Rise, Check Interest Rates Here
- Education NTA Released ICAR AIEEA Result 2022 For UG programmes; Direct Link Here
- Automobiles Kia India Registers Highest Ever Monthly Sales - 25,87 Units Sold In September 2022
- Technology Jio, Airtel, and Vi 5G Services in India; Here's How Fast Your Internet Will Be
- Travel List of The Shortest Rivers In The World
Omicron sub-variant BA.2's offspring BA.2.38 has not led to any increase in hospitalisation or disease severity, and a few deaths reported recently are due to comorbidities, Insacog said in its June 20 bulletin released on Sunday.
In the bulletin, the Indian SARS-CoV-2 Genomics Consortium (Insacog) said many BA.2 cases have been reclassified to BA.2.38 and it seems to be the prevalent sub-lineage in the latest sequencing batches, it said.
"However, so far, this has not led to any increase in hospitalisation or any report of an increase in disease severity. A few deaths that have been reported recently are due to comorbidities. COVID-appropriate behavior is likely to reduce the spread of the infection and hence continues to be recommended," it said.
In its previous bulletin dated June 13, which was also released on Sunday, the Insacog said BA.2 continues to be the dominant lineage in India.
"However, hospitalisation due to the severity of the disease has not been observed that much. INSACOG is closely monitoring the current situation," it said.
In another bulletin dated May 30, the Insacog informed us that till then, five cases of BA.4 and three cases of BA.5 had been reported in India.
The Insacog reports genomic surveillance of SARS-CoV-2 across the country through sequencing of samples from sentinel sites and international passengers arriving in India.
- disorders cureWhat Is ‘Centaurus,’ New Fast-Spreading Covid Variant: Everything You Need To Know
- health75 Years Of Independence, 75 Days Of Free COVID Booster Shots; For Everyone Aged 18-59 From 15 July
- wellnessWhat Are The Health Risks Of Getting COVID The Second Or Third Time? 7 Important Points
- wellnessIllnesses Caused By BA.2.38 Are Mild, Self-Limiting, Says Covid-19 Study
- wellnessGenome Sequencing Tests Show Omicron Dominating In Karnataka: Health Minister
- wellnessHow Does COVID Spread During Short Conversations?
- wellnessLong Covid-19 Risk Less With Omicron Than Delta Variant, UK Study Finds
- wellnessMore Contagious Subvariant Of Omicron Detected In Russia: What You Need To Know
- wellnessOmicron Subvariants BA.4 And BA.5 In India: What You Need To Know
- wellnessHaven't Had Covid-19 Yet? It Could Be More Than Just Luck
- wellnessSouth Africa In New Surge Of COVID-19 From Versions Of Omicron
- wellnessCovid-19 Cases May Rise In June-July, Speeding Up Vaccination Drive Best Way Ahead, Says Maharashtra Minister